Cardeas Pharma competitorsClear all

Cardeas Pharma's top competitors include Biogen, Athersys, Reata Pharmaceuticals and Ironwood Pharmaceuticals.
Cardeas Pharma
Cardeas Pharma
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
2010
Founding Date
1978
Founding Date
1995
Founding Date
2002
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Cleveland, US HQ
Canton, US
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
N/A
Employees
7,4005% decrease
Employees
8311% increase
Employees
22079% increase
Employees
31738% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
43.3 b
Valuation ($)
402.7 m
Valuation ($)
3.2 b
Valuation ($)
1.5 b
Twitter followers
Twitter followers
N/A
Twitter followers
34 k
Twitter followers
2 k
Twitter followers
963
Twitter followers
3.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
71
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
31.3
Average likes per tweet (last 30 days)
34.8
Average likes per tweet (last 30 days)
4.7
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
94.12%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
254464
Alexa Website Rank
322595
Alexa Website Rank
365810
Alexa Website Rank
313890
Employee Rating
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
5
Employee Rating
4
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$5.6m (FY, 2019)
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$428.4m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$2b (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$23.9m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$12.4b (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
$404.5m (FY, 2019)
Net income
Net income
N/A
Net income
$5.9b (FY, 2019)
Net income
($44.6m) (FY, 2019)
Net income
($290.2m) (FY, 2019)
Net income
$21.5m (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
34 (FY, 2019)
Patents Issued
200 (FY, 2016)
Patents Issued
240 (FY, 2016)
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
11 (Q2, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (Q2, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q2, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 46m
Total funding raised
N/A
Total funding raised
$ 9m
Total funding raised
$ 468.9m
Total funding raised
$ 609m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company